|
Stages III–IV (n=41)
|
Univariate
|
Multivariate
|
|---|
| |
HR
|
95% CI
|
p-value
|
HR
|
95% CI
|
p-value
|
|---|
|
High Wip1
|
4.93
|
1.70–14.3
|
0.0033
|
3.98
|
1.38–11.5
|
0.011
|
|
Positive p53
|
0.98
|
0.40–2.40
|
0.96
|
-
|
-
|
-
|
|
High phospho-p53
|
0.35
|
0.10–1.21
|
0.097
|
-
|
-
|
-
|
|
High nuclear phospho-p38
|
7.86E+07
|
0–Inf
|
1.00
|
-
|
-
|
-
|
|
High cytoplasmic phospho-p38
|
0.48
|
0.20–1.14
|
0.096
|
-
|
-
|
-
|
|
Age ≥60
|
0.46
|
0.17–1.25
|
0.13
|
-
|
-
|
-
|
|
Positive peritoneal cytology
|
1.03
|
0.30–3.48
|
0.96
|
-
|
-
|
-
|
|
Residual tumor present
|
2.72
|
1.45–6.48
|
0.024
|
2.39
|
0.98–5.79
|
0.055
|
|
Endometriosis present
|
0.82
|
0.34–1.96
|
0.66
|
-
|
-
|
-
|
|
Lymphadenectmy undone
|
1.62
|
0.70–3.75
|
0.26
|
-
|
-
|
-
|
|
Adjuvant chemotherapy performed
|
NA
|
NA
|
NA
|
-
|
-
|
-
|
|
Pure histology
|
1.79
|
0.42–7.66
|
0.43
|
-
|
-
|
-
|
- OS overall survival, HR hazard ratio, CI confidence interval, Inf infinity, NA not applicable
